Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Single Dose Pharmacokinetics of Oral EC5026 in a Population With Chronic Kidney Disease

NCT07694544 is registered in ClinicalTrials.gov with EicOsis Human Health Inc. as lead sponsor.

NCT NCT07694544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07694544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Single Dose Pharmacokinetics of Oral EC5026 in a Population With Chronic Kidney Disease
Lead sponsor
EicOsis Human Health Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
July 1, 2026
Completion date
June 30, 2027
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease